跳至主要内容
临床试验/NCT05167045
NCT05167045
已完成
不适用

A Pilot Study for the Brain Health Support Program (BHSP) Intervention of the Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia

Baycrest6 个研究点 分布在 1 个国家目标入组 20 人2021年11月15日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Dementia
发起方
Baycrest
入组人数
20
试验地点
6
主要终点
Functionality of the BHSP
状态
已完成
最后更新
3个月前

概览

简要总结

Prior studies have shown that programs that focus on promoting brain health and managing lifestyle risks (such as poor diet, obesity, physical inactivity, sleep issues, loneliness) may help in preventing or lowering the risk of dementia. To address this, investigators have developed the CAN-THUMBS UP program to conduct studies that target lifestyle risk and focus on dementia prevention. An online Brain Health Support Program (BHSP) has been developed. The BHSP is an educational program designed to teach about dementia. Before the full BHSP is offered to a large group, we are conducting an initial pilot study to help assess the usability of the program.

注册库
clinicaltrials.gov
开始日期
2021年11月15日
结束日期
2022年4月29日
最后更新
3个月前
研究类型
Observational
性别
All

研究者

发起方
Baycrest
责任方
Principal Investigator
主要研究者

Howard Chertkow

Scientific Director, Canadian Consortium on Neurodegeneration in Aging

Baycrest

入排标准

入选标准

  • Meets criteria for No Dementia and one of the following (according to CCNA criteria):
  • Cognitively Intact (CI) Cognitively Intact plus Subjective Cognitive Impairment (CI + SCI) Mild Cognitive Impairment (MCI)
  • AND Classified as being at increased risk of dementia based on at least one of the following: First-degree family history of dementia
  • Self-Reported or documented current and/or history at midlife (45-60) on any of the following risk factors:
  • Hypertension (documented Systolic Blood Pressure \> 140 mm Hg; OR physician diagnosis of hypertension; OR treatment for hypertension; OR other approaches to treatment (e.g. diet, exercise))
  • Hypercholesterolemia (documented total cholesterol \> 6.5 mmol/L; OR physician diagnosis of hypercholesterolemia; OR treatment for hypercholesterolemia; OR other approaches to treatment (e.g. diet, exercise))
  • Body Mass Index \> 30 kg/m2 (derived from NIH Metric BMI Calculator)
  • Physical Inactivity (active is defined as engaging in a minimum of 20- 30 min of physical activity causing sweating and breathlessness, at least 2 times a week)

排除标准

  • 未提供

结局指标

主要结局

Functionality of the BHSP

时间窗: Nov 2021-Mar 2022

Functionality of the web-based components of the BHSP measured in the pilot and qualitative focus group(s) questions

User acceptance of the BHSP

时间窗: Nov 2021-Mar 2022

User adherence and engagement using the online program during the pilot including dates and times of use, duration of use and completion of program assessments

Usability of the BHSP

时间窗: Nov 2021-Mar 2022

User satisfaction and evaluation of usability and acceptability of BHSP measured during the pilot and focus group(s)

To assess participant satisfaction with the organization, presentation and personalization of the BHSP content

时间窗: Nov 2021-Mar 2022

Qualitative evaluation of participant responses during the focus group discussion

To evaluate the feasibility of remote data collection

时间窗: Nov 2021-Mar 2022

User data, feedback and adherence to remote measures, such as: Screening evaluation by tele/video-conference, Neuropsychological Test Battery, Burst cognitive testing with the MyCogHealth app, online version of the Cogstate Brief Battery, Assessments of lifestyle risk factors (sleep, diet, mood, cognition, physical activity, vascular health, social and psychological health, vision and hearing), Actigraphy and EEG wearables as measures of total daily physical activity and sleep fragmentation, and Saliva sample collection for genomics testing (Polygenic Hazard Score)

研究点 (6)

Loading locations...

相似试验